AstraZeneca: $1B Heart Drug Deal

December 21, 2005

142

AstraZeneca PLC signed a heart drug deal worth up to $1 billion with biotechnology company AtheroGenics Inc. on Thursday, as it stepped up efforts to restock a pipeline depleted by past product setbacks.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Western Digital Soars

Meade Slowed By Asia Supply Issue

staff-author

AstraZeneca: $1B Heart Drug Deal

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Photos: Inside R.D. Olson’s Hotel Projects in Dana Point

Inside The $17M Sale of A 7,600SF Dana Point Ritz Cove Estate

Inside Look at Phase 1 of the $4B OCVibe District in Anaheim

Related Articles

Photos: Inside R.D. Olson’s Hotel Projects in Dana Point

Inside The $17M Sale of A 7,600SF Dana Point Ritz Cove Estate

Inside Look at Phase 1 of the $4B OCVibe District in Anaheim

Possible Redevelopment Forces Closure of Gulliver’s

El Pollo Loco Authorized to Repurchase Up to $40M in Shares

Advertise With Us

About Us

Subscriber Links

Other Journals